Special reminder: The overall market situation of domestic animal medicine raw materials has declined.
01 Penicillin and cephalosporins
Penicillin products generally operate weakly.
Amoxicillin and amoxicillin sodium. Amoxicillin, in the third week of April, the market was weak and the decline increased; Amoxicillin sodium, market price 300-340, weak trend in April market.
Amoxicillin and clavulanic acid potassium, with weak performance, market price of 485, a month on month decrease of 2.5%, a year-on-year decrease of 34.9%, the lowest point in the same period of the past five years, and a downward trend in the market in April.
Ampicillin and Ampicillin Sodium. Ampicillin is running smoothly, with little change in the market compared to last week; Ampicillin sodium 280-325, showing a downward trend in the market in April.
Penicillin sodium, with a market price of 109-119 billion yuan, increased by 0.3% month on month, narrowed by 0.3 percentage points in decline, and decreased by 29.3% year-on-year, hovering at a low level in the past five months.
Penicillin potassium industrial salt, operating weakly, with a trading price of 59-69/billion, a month on month decrease of 1.2% and a year-on-year decrease of 39.3%, hitting a new low in nearly six months.
Cefotaxime Sodium, Cefotaxime Hydrochloride, Cefotaxime Sulfate. Cefotaxime sodium, running smoothly, with a market price of around 850; Cefotaxime hydrochloride, market price fluctuating and consolidating, market price 780-880; Cefotaxime sulfate, operating weakly, has a market price of 3930, with a month on month decrease of 0.3% and a year-on-year decrease of 18.9%. The average prices for the same period in the past five years from 2025 to 2021 were 4880, 5520, 6158, 6900, and 8350, respectively.
All rights reserved for original articles by Asia Pacific Yihe Data Analysis Research Institute. Market data analysis is a comprehensive price of bulk products and is not used as an investment basis.
02 Chloramphenicol and Tetracyclines
Tetracycline products generally operate weakly.
Flufenicol, in the third week of April, the market situation remained stable, with significant differences in transaction prices among different regions and brands.
Thiamphenicol has been running steadily, with a market price of 177, a month on month increase of 0.9%, and a year-on-year decrease of 11.5%. The average prices for the same period in the past three years from 2025 to 2023 were 198, 235, and 303, respectively. The market trend remained stable in April.
Hydrochloric acid doxycycline runs weakly, with an increasing decrease in April.
Oxytetracycline, oxytetracycline hydrochloride. Oxytetracycline, the market is stable, with little change compared to last week's market; Oxytetracycline hydrochloride has entered April with active trading and high popularity. The transaction prices vary greatly depending on the region and brand, with a trading range of 93-103. The average prices for the same period in the past five years from 2025 to 2021 were 92, 93, 97, 108, and 114, respectively.
Chlortetracycline hydrochloride, with a market price of 155, has increased in price compared to last week, with a year-on-year decrease of 10.4%.
Chloramphenicol products, such as florfenicol, had a low and stable market in the first quarter of January and February, with average prices of 169, 160, and 164, respectively. The market rebounded slightly at the end of February and the beginning of March, with a price range of 159-169 in March; The average price of methicillin in the first quarter was 169.
03 Aminoglycosides
The overall market for aminoglycoside products has declined.
Neomycin sulfate has an overall stable market price of 145-155 billion yuan, with a stable trend in April.
Hydrochloric acid (sulfuric acid) spectinomycin has rebounded in the market, with a narrowed increase in price. The average market prices from April 2025 to 2023 are 570, 495, and 513, respectively.
Streptomycin sulfate, the market trend is stabilizing, with a price range of 265-315 yuan per billion yuan.
Amphotericin sulfate is stable with some increase, slightly higher than last week's market. The trading prices for the same period in 2025 and 2024 are both higher than the average prices from 2002, 2025 to April 2023, which are 205, 214, and 205, respectively.
The market transaction price of kanamycin monosulfate is 299/billion, with a month on month increase of 0.4%. The transaction price remained the same as last year, and the market trend in April was relatively strong.
Amikacin sulfate has a market price of 730, with little change compared to last week's market trend.
Gentamicin sulfate, the market is stable.
The overall trend of aminoglycoside products remained stable in the first quarter. Neomycin sulfate showed a trend of "stable start - narrow stability - slight decline", with prices mainly fluctuating within a narrow range of 153-155/billion in January and February. In March, the price range shifted downwards to 145-155/billion, with a year-on-year decline expanding from 3% to 6%. The market is in the stage of destocking, and downward pressure continues to exist, but the fluctuation is not significant during the quarter. The heat and trading activity have increased in mid to late March; The transaction price range of chloramphenicol hydrochloride is 535-555, with an increase of over 3%; Streptomycin sulfate 265-310; The average prices of ampicillin sulfate and kanamycin sulfate monosulfate are 191 and 294, respectively.
04 Macrolides and other antibiotics
The overall market for macrolide products is stable.
Tartrate tylosin has high popularity and active trading, with a market price of around 275, which is basically the same as last week's transaction price.
Tilmicosin and Tilmicosin phosphate. Timikaoxing, market price 359; Phosphatomikacin has a market price of 310, which is basically the same as last week's price, with a year-on-year decrease of 3.2%.
Tartrate guitarimycin has not changed much compared to last week's market trend.
Tartrate tetracycline has a trading market price of 370-399, which is basically the same as last week's price, with a year-on-year increase of 4.2%.
Teramycin, market price 5980, stable trend in April.
Erythromycin thiocyanate, with high popularity and active trading, has a stable and rising market price range of 465-495, with a month on month increase of 1.8% and a year-on-year decrease of 4.4%. The market trend remained stable in April.
Sulfuric acid colistin, with tight supply and a stable but rising market price of 115, has increased compared to last week's transaction price.
Yanhusuo acid and Taimiao mushroom extract have fluctuated and consolidated, with little change in the market compared to last week.
Lincomycin hydrochloride, with a stable average price and a slight decline this week, has a market price of 305-339 billion yuan, a month on month decrease of 0.5% and a year-on-year decrease of 19.2%. This also confirms that the market supply this year is better than last year. The average prices from January to March in the first quarter of last year were 443, 439, and 420, respectively; The average prices for January to March 2024 are 298, 305, and 299, respectively.
Original article by Asia Pacific Yihe Data Analysis Research Institute. Reproduction without permission is prohibited and infringement will be investigated. Please contact the author for reproduction and citation, and indicate the original source.
05 Quinolones
Quinolone products undergo oscillation adjustment.
Enrofloxacin, Enrofloxacin Hydrochloride. Strong operation, market price around 170, intermediate price increase, cost pressure, April market trend upward.
Lactic acid (hydrochloric acid) ciprofloxacin, priced at 160, has a stable overall market, with a year-on-year decrease of 11.3% compared to last week. The average prices from 2025 to April 2023 are 186, 196, and 234, respectively.
Salafloxacin hydrochloride has a stable market price of 390.
Mabofloxacin, market price 2250, decreased by 1.2% month on month and 15.7% year-on-year.
06 Sulfonamide class
The overall market for sulfonamide products is stable.
Sulfonamide methoxypyrimidine (sodium), with a strong trend, has not changed much compared to last week's market.
Sulfonamide trimethoprim (sodium), with a strong tendency to operate, has a market price of 235-245.
Sulfamethoxazole (sodium), market price 100-145.
Sulfonamide (sodium) has a stable market price of 155, with average prices of 165, 161, and 201 for the same period from 2025 to 2023.
Sulfamethoxazine (sodium), market price 99-109, stable compared to last week, with a year-on-year increase of 24.4%.
Sodium sulfaquinoxaline remained relatively stable compared to last week, with a year-on-year increase of over 20%. The average prices from 2025 to April 2023 were 174, 169, and 295, respectively.
Sodium sulfamethoxazole remained relatively stable compared to last week, with average prices of 215, 228, and 300 from 2025 to April 2023, respectively.
Sodium sulfamethoxazole remained relatively stable compared to last week, with average prices of 171, 140, and 180 from 2025 to April 2023, respectively.
Dimethyl trimethoprim, with tight supply and rising prices, the market price is 400.
Trimethoprim, Trimethoprim lactate. Trimethoprim, market price 245; Lactic acid trimethoprim, market price 190.
07 Antiparasitic class
Anti parasitic products operate smoothly overall.
Albendazole, with a strong performance, has a market price of around 150, with a month on month increase of 3.5% and a year-on-year decrease of over 6.5%. There are significant differences in transaction prices among different regions and brands. The market opened low and rose in the first quarter, bottomed out at the end of January, and continued to operate at a low level until February. In mid March, it entered the fast lane of growth, and in the second quarter, the market remained stable with an upward trend.
Fenbendazole, with a strong performance, has a market price of 265, with a month on month increase of 1.9% and a year-on-year increase of 8.2%.
Abamectin, with active trading, continues to rise in the market with a trading price of around 630, showing an upward trend in April.
Ivermectin, with a strong tendency to operate, has a market price of 800. The average prices for the same period in the past five years from 2025 to 2021 were 789, 846, 1092, 1460, and 1410, respectively.
Dikezhuli, with a market price of 1030, has risen from last week's market trend, with a year-on-year increase of 3.0%.
Tuoqu Zhuli, with a strong operating trend and a market price of 860.
Levamisole hydrochloride has a stable market.
Aminopyrine hydrochloride has a stable market.
Metronidazole has a stable market, with prices basically unchanged from last week, a year-on-year decrease of 4.6%. The average prices for the same period from 2025 to 2023 are 79, 78, and 85, respectively, indicating an upward trend in the market in April.
Dimetronidazole prices remained relatively stable compared to last week, with a year-on-year increase of 6.7%. The average prices for the same period from 2025 to 2023 were 89, 99, and 147, respectively.
Praziquantel, with a market price of around 320, has seen a narrowing increase and a decrease of nearly 100 yuan in unit price compared to the same period last year, indicating an upward trend in the market in April.
Cyclopropane, with high popularity and active trading, has a market price of 120 and an upward trend in the April market.
All rights reserved for original articles by Asia Pacific Yihe Data Analysis Research Institute. The market data analysis is based on the comprehensive prices of bulk products.
08 Antipyretic, analgesic, anti asthmatic, and immune boosting products
The overall trend of antipyretic and analgesic products is stable.
Flunixin meglumine has a market price range of 369-385, with a month on month decrease of 0.4% and a year-on-year decrease of over 10%, indicating a downward trend in the market in April.
An Naijin, the market is stable.
Acetaminophen, the market fluctuated and adjusted.
Aminopyrine, market price 100, stable compared to last week, with a year-on-year decrease of 2.9%.
Aminophylline has a stable market price of 107.
Aspirin, market price 18800/ton.
Taurine, the market trend continues to be strong, with upstream prices mainly rising and downstream demand gradually slowing down. Demand based procurement is the main approach, and the overall transaction atmosphere in the market appears lukewarm.
Kabapilin Calcium, after a strong market rally in March, entered a market correction in April. The trading market continued to decline this week, with a rise of over 10% in the first quarter.
09 Veterinary drug excipients and other categories
Acetyl methyl quinoline, market fluctuation adjustment.
Camphor sulfonate sodium, the market fluctuates and adjusts.
Pumin, with a downward trend, experienced a volatile rise in early March of the first quarter and entered a market downturn in April.
Sodium salicylate, the market has rebounded, with a trading price of 26300/ton.
Citric acid, tight supply, rising market price, market price 4590/ton.
Sodium citrate, the supply is tight, the market is rising, and the market price is 4690/ton.
Sodium carbonate, with a stable market price of 2120/ton.
Sodium bicarbonate, with a stable market price of 2400/ton.
Glucose, trading price 3850-6400/ton, with an upward trend.
Jiayi Powder has a trading price of 2680-3260/ton, and the market is stabilizing.
Soluble starch, with strong performance, market price of 12600/ton.
Beta cyclodextrin, with strong operation, market price of 18300/ton.
For more information, please join the Asia Pacific Yihe Data Analysis Research Institute as a member to stay up-to-date with market changes.
10 plant raw materials and traditional Chinese medicinal materials
The overall trend of medicinal herbs in plant raw materials is stable.
Shuanghuanglian extract, 60-110.
Astragalus polysaccharide extract, 50-100.
Scutellaria baicalensis extract, 110-150.
Licorice extract, 60-100.
Honeysuckle extract, 69-110.
Honeysuckle, 55-120.
Huanglian, 240-290.
Huangqi, 9-12.
Huangqin, 16-25.
Yanhusuo, 55-65.
Chenpi, 10-13.
Hawthorn, 5-8.
Licorice, 10-14.
Dried ginger, 16-25.
Red flower, 50-79.
Banlangen, 18-29.
11 Vitamins
After a rapid rise in March, the market for vitamin products slowed down in April, with some products experiencing a downturn.
VA， Mix 120, water-soluble 140, stable market.
VB1， The market is stable, with nitric acid 240 and hydrochloric acid 290.
VB2， 98% price is 278, 80% price is 76.
VB6， The market is stable, with a market price of 115.
VB12 1% ， The market price is 100, and the market is stable.
VC， The market price is around 21 for feed grade and 30 for pharmaceutical grade, with an upward trend in the market.
VD3， The market price for mixed materials is 145, with a water solubility of 165, and the market trend is slowing down.
VE， Mixing material 110, water-soluble 125, the market is on the rise.
VK3， The market price is 100, stable with an upward trend.
Calcium pantothenate, market price 105, continues to rise.
Niacinamide, market price 50, stable market.
Biotin 2%, market price 39.
Folic acid, market price 320, market decline.
